Cefpirome is a fourth-generation parenteral cephalosporin offering broad-spectrum coverage against Gram-positive and Gram-negative pathogens including some Pseudomonas strains. Simson Pharma's Cefpirome reference standard and impurities support compendial testing for this injectable beta-lactam.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cefpirome Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.